|
|
|
|
| LEADER |
01911nam a22003735i 4500 |
| 001 |
978-3-319-24223-1 |
| 005 |
20191028231348.0 |
| 007 |
cr nn 008mamaa |
| 008 |
151214s2016 gw | s |||| 0|eng d |
| 020 |
|
|
|a 9783319242231
|
| 024 |
7 |
|
|a 10.1007/978-3-319-24223-1
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Lung Cancer and Personalized Medicine
|b Current Knowledge and Therapies /
|c edited by Aamir Ahmad, Shirish Gadgeel.
|
| 250 |
|
|
|a 1st ed. 2016.
|
| 260 |
# |
# |
|a Cham :
|b Springer International Publishing :
|b Imprint: Springer,
|c 2016.
|
| 300 |
|
|
|a XIII, 228 p. 26 illus., 14 illus. in color.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Advances in Experimental Medicine and Biology,
|v 893
|
| 505 |
0 |
|
|a 1 Lung Cancer Statistics -- 2 Epidemiology of Lung Cancer -- 3 Lung Cancer In Never Smokers -- 4 Immune Therapy -- 5 Anti-angiogenesis in personalized therapy of lung cancer -- 6 Target therapy in Lung Cancer -- 7 Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors and Therapeutic Approaches: an update -- 8 KRAS-Mutant Lung Cancers in the Era of Targeted Therapy -- 9 Anaplastic Lymphoma Kinase (ALK) Signaling in Lung Cancer -- 10 Chemotherapy Resistance in Lung Cancer -- 11 Current state of metal-based drugs for the efficient therapy of lung cancers and lung metastases.
|
| 650 |
|
0 |
|a Cancer research.
|
| 650 |
|
0 |
|a Molecular biology.
|
| 650 |
|
0 |
|a Internal medicine.
|
| 650 |
|
0 |
|a Oncology .
|
| 650 |
1 |
4 |
|a Cancer Research.
|
| 650 |
2 |
4 |
|a Molecular Medicine.
|
| 650 |
2 |
4 |
|a Internal Medicine.
|
| 650 |
2 |
4 |
|a Oncology.
|
| 700 |
1 |
|
|a Ahmad, Aamir.
|e editor.
|
| 700 |
1 |
|
|a Gadgeel, Shirish.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-319-24223-1
|